The Internet as a Tool for Liver Transplant Programs to Combat Stigma Related to Alcohol Use Disorder
Michael Pimienta, Jennifer Dodge, Norah A. Terrault – 31 January 2021
Issue Information
31 January 2021
Molecular Mechanisms Linking Nonalcoholic Steatohepatitis to Cancer
Kara Wegermann, Jeongeun Hyun, Anna Mae Diehl – 31 January 2021
CON: Noninvasive Imaging Is the Preferred Strategy for Cardiovascular Risk Stratification in This Patient
Shravan Dave, Abbey Barnard, Michel Mendler – 31 January 2021
Correction
31 January 2021
Seeking Editor for Hepatology Communications
31 January 2021
Scientific Relief: When Science and Technology Agree and Lead
Mohammad Qasim Khan, Kymberly D. Watt – 30 January 2021
Reply
Alyson Kaplan, Brett Fortune, Nneka Ufere, Robert S. Brown, Russell Rosenblatt – 26 January 2021
Gut Microbial Signature of Hepatocellular Cancer in Men With Cirrhosis
Somaya Albhaisi, Amirhossein Shamsaddini, Andrew Fagan, Sara McGeorge, Masoumeh Sikaroodi, Edith Gavis, Samarth Patel, Brian C. Davis, Chathur Acharya, Richard K. Sterling, Scott Matherly, Michael Fuchs, Patrick M. Gillevet, Jasmohan S. Bajaj – 24 January 2021 – The gut microbiome is altered in cirrhosis. Recent evidence has suggested a key role for the gut microbiota in the progression of cirrhosis and the development of hepatocellular carcinoma (HCC).
Outcomes in Living Donor Compared With Deceased Donor Primary Liver Transplantation in Lower Acuity Patients With Model for End‐Stage Liver Disease Scores <30
Toshihiro Kitajima, Dilip Moonka, Sirisha Yeddula, Kelly Collins, Michael Rizzari, Atsushi Yoshida, Marwan S. Abouljoud, Shunji Nagai – 24 January 2021 – Although recent studies have reported favorable outcomes in living donor liver transplantation (LDLT), it remains unclear which populations benefit most from LDLT. This study aims to evaluate LDLT outcomes compared with deceased donor LT (DDLT) according to Model for End‐Stage Liver Disease (MELD) score categories.